Global Psoriatic Arthritis Drugs Market 2018 | Status( 2013-2017) and Forecast(2018-2025) - Daily Business Report (blog)

 
 
Daily Business Report (blog)Global Psoriatic Arthritis Drugs Market 2018 | Status( 2013-2017) and Forecast(2018-2025)Daily Business Report (blog)TNF Inhibitors, PDE4 Inhibitors, Interleukin Blockers, Other. Applications covered in Psoriatic Arthritis Drugs industry-. Mild Psoriatic Arthritis, Moderate Psoriatic Arthritis, Severe Psoriatic Arthritis. More details, inquiry about report and table ...and moreá╗
 
Related NewsFeeds

Motley FoolWill This Biotech Stock Join the $1000 Human Genome Club in Early 2019?Motley FoolFor similar reasons, long-read tech is better-suited for precise genome engineering applications (like in a

20 visits

Motley FoolProfit Keeps Piling Up for Ligand Pharmaceuticals -- The Motley FoolMotley FoolThis fast-growing biotech delivered yet another quarter of strong profits while keeping risks low for its shar

0 visits

OncLiveCabozantinib in mRCCOncLiveSome of interest include the traditional VEGF inhibitors, and we have looked at things like Inlyta (axitinib). We've looked at Sutent (sunitinib) and Votrient (pa

1 visits

Financial TimesChina biotech looks to make leap from 'fast followers'Financial TimesMr Han was an early mover in what has become among the hottest areas in venture capital: biotech. Last year,

1 visits

Titan Pharmaceuticals: 2Q Earnings SnapshotHouston ChronicleSAN FRANCISCO (AP) _ Titan Pharmaceuticals Inc. (TTNP) on Tuesday reported a loss of $869,000 in its second quarter. The San Francisco-based

1 visits

TNF inhibitors do not seem to boost cancer-recurrence ratesMD Linx (press release)TNF has both tumor-promoting and cancer-protective effects, so TNF inhibitors could conceivably affect the risk for ca

1 visits

Why Traders Are Chasing OneSpan Inc. (OSPN), China Biologic Products Holdings, Inc. (CBPO)Analyst JournalOneSpan Inc. (NASDAQ:OSPN) shares ended at $17.3 with 0.18 mln shares exchanging hands. That pu

1 visits

Synergy Pharma: Sales Ramp IgnoredSeeking AlphaSynergy Pharma (SGYP) has made several rallies towards $2, but the biotech stock hasn't held any gains despite improving prescription numbers for Tru

1 visits

Eton Pharmaceuticals Files For US IPOSeeking AlphaEton Pharmaceuticals intends to raise $21 million in an IPO of its common stock. The firm is advancing a pipeline of reformulations of existing treatm

1 visits

Endpoints NewsAcorda CTO Batycky is jumping ship to run a biotech; Motif gets a PDUFA dateEndpoints NewsWe have one more news item about a biotech exec on the move. Acorda's $ACOR chief technology

18 visits

Realm Phase II Trial Fails to Reach EndpointsPharmaLive (press release)Written by: BioSpace | news@biospace.com | Dated: Tuesday, August 14th, 2018. By Alex Keown. Shares of Realm Therapeutics have pl

5 visits

Baylor College of Medicine News (press release) (blog)Healthy fat cells uncouple obesity from diabetesBaylor College of Medicine News (press release) (blog)About 422 million people around the world, i

1 visits

'Alarming' diabetes epidemic in Guatemala tied to aging, not obesityScience DailyThe diabetes epidemic in Guatemala is worse than previously thought: more than 25 percent of its indigenous peo

1 visits

Bayer teams up with Evotec, HaplogenPharmaLive (press release)Evotec AG and Haplogen GmbH have been long-term collaboration partners. The companies announced that Haplogen will enter into a multi-year

1 visits

MedscapeDiabetes Resource for 'Overwhelming' Numbers of Devices, AppsMedscapeAccording to an AADE statement, "Technology has been a game changer in helping people with diabetes manage their bl

1 visits

New NIH reference book is one-stop resource for diabetes medical informationNational Institutes of Health (press release)Thanks to research, what we know about diabetes and how to treat it has grown v

1 visits

BenzingaThe Daily Biotech Pulse: Cesca, Acer Therapeutics Rally On Earnings, Aridis Makes Its Nasdaq DebutBenzingaSee Also: The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs. ENDR

1 visits

Nikkei Asian ReviewSun Pharmaceuticals profit beats estimates on rising US salesNikkei Asian ReviewMUMBAI (NewsRise) -- Sun Pharmaceutical Industries reported a better-than-expected first-quarter prof

1 visits

Wiggling Stocks: FireEye, Inc. (NASDAQ:FEYE), Box, Inc. (NYSE:BOX), China Biologic Products Holdings, Inc ...The Stock Street (press release)Hot Stocks: FEYE, BOX, CBPO are discussed below. FireEye, I

1 visits

Business WirePreparing Health Network CEOs for Success with Precision ...Digital Journalsystems. September 12-13 in Nashville, experts from the nation's most.Preparing Health Network CEOs for Succ

1 visits